Cancer risk reduction

If POM's recent actions are anything to go by, it won't take the FTC's motion to dismiss lying down

FTC to POM: Our claim standards are not new

By Shane Starling

The Federal Trade Commission (FTC) says it has not set any new claim substantiation “rules” in a new court action against California-based pomegranate player, POM Wonderful.

Oxford researchers say reduced homocysteine levels don't reduce CV events

Meta-analysis questions folic acid’s heart benefits

By Stephen Daniells

Increased intakes of folic acid – a synthetic form of folate – may decrease blood levels of the amino acid homocysteine, but this does not translate into reductions in cardiovascular events, says a new meta-analysis from the University of Oxford.

Selenium qualified cancer claims: FDA approved (with disclaimer)

Selenium qualified health claims are usable, says attorney

By Shane Starling

The legal counsel who represented Durk Pearson, Sandy Shaw and others in the recent case that forced the Food and Drug Administration (FDA) to alter three approved selenium health claims, says his clients and others will use the claims.

EVEn keel: The claim-making furore hasn't stopped POM launching a provocative campaign

FTC complaint may influence other POM Wonderful legal actions

By Shane Starling

Pomegranate leader POM Wonderful and Pepsi-owned Tropicana – locked in a legal battle over juice claims – have been asked to submit comments about the complaint lodged against POM by the Federal Trade Commission last month.

POM: The legal saga rolls on

FTC bombs POM (and researchers beware)

By Shane Starling

The Federal Trade Commission legal action alleging POM Wonderful made unsubstantiated claims for its pomegranate products, adds to a stream of claim actions the increasingly active agency has taken this year.

Nano-EGCG could take tea benefits into clear beverages

Nano-EGCG could take tea benefits into clear beverages

By Stephen Daniells

Modified whey protein may nano-encapsulate the green tea compound EGCG and slow its rate of degradation 3.2-fold, thereby offering nano-encapsulation potential for formulators, says a new study.

US Vitamin K market set for explosion?

US Vitamin K market set for explosion?

By Stephen Daniells

With the entrance of a new vitamin K2 ingredient onto the US market, NutraIngredients-USA catches up with the state of play of vitamin K.

POM: Engaged in legal battles on many fronts

Class action lodged against POM Wonderful

By Shane Starling

A class action has been lodged in a Florida state court alleging POM Wonderful misled consumers with at least six different health claims, as the Californian pomegranate pioneer’s legal battles multiply.

The quest for a radical new world for antioxidants

The quest for a radical new world for antioxidants

Here’s a radical thought for the marketers - the benefits of antioxidants may not be related to antioxidant activity. Last week’s NutraIngredients Antioxidants Conference suggested some tough choices are ahead.